1. Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway
   Yang Wang et al, 2022, Journal of Ethnopharmacology CrossRef
2. Structural Diversity and Biological Activities of Diterpenoids Derived from Euphorbia fischeriana Steud
   Baiyu Jian et al, 2018, Molecules CrossRef
3. Anti-Cancer Activities of Diterpenoids Derived from Euphorbia fischeriana Steud
   Baiyu Jian et al, 2018, Molecules CrossRef
4. Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones
   Yulin Ren et al, 2020, Journal of Medicinal Chemistry CrossRef
5. Evaluation of the Anticancer Potential of Morus nigra and Ocimum basilicum Mixture against Different Cancer Cell Lines: An In Vitro Evaluation
   Bader O. Almutairi et al, 2023, BioMed Research International CrossRef
6. Ethanolic extract of Euphorbia Gypsicola induces differentiation and apoptosis in human myeloid leukemia K562 cells
   Monireh Zare et al, 2024, European Journal of Integrative Medicine CrossRef
7. Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis
   Caixia Gao et al, 2016, Scientific Reports CrossRef
8. The effects of jolkinolide B on HepG2 cells as revealed by 1H-NMR-based metabolic profiling
   Yujing Yan et al, 2019, European Journal of Pharmacology CrossRef
9. Terpenoids A Potential Scaffold for Cancer Therapy: A Mechanistic Approach
   Surya Kant Tripathi et al, 2023, Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach CrossRef
10. A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway
    Liwei Ma et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
11. Anticancer properties of Tulbaghia violacea regulate the expression of p53-dependent mechanisms in cancer cell lines
    Lesetja R. Motadi et al, 2020, Scientific Reports CrossRef
12. A screening of growth inhibitory activity of Iranian medicinal plants on prostate cancer cell lines
    Majid Asadi-Samani et al, 2018, BioMedicine CrossRef
13. Integrated Strategy of UHPLC-Q-TOF-MS and Molecular Networking for Identification of Diterpenoids from Euphorbia fischeriana Steud. and Prediction of the Anti-Breast-Cancer Mechanism by the Network Pharmacological Method
    Tian-Cheng Ma et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
14. Jolkinolide B: A comprehensive review of its physicochemical properties, analytical methods, synthesis and pharmacological activity
    Ya-Yao Zhang et al, 2022, Phytochemistry CrossRef
15. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein
    Tianchun Wu et al, 2024, PLOS ONE CrossRef
16. Plant-derived diterpenes for breast cancer treatment: New perspectives and recent advances
    Fernanda Tomiotto-Pellissier et al, 2022, Bioactive Natural Products CrossRef
17. SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer
    Surya Kant Tripathi et al, 2021, Life Sciences CrossRef
18. The effect of Euphorbia szovitsii Fisch. & C.A.Mey extract on the viability and the proliferation of MDA-MB-231 cell line
    Majid Asadi-Samani et al, 2019, Bioscience Reports CrossRef
19. Existing knowledge on Euphorbia fischeriana Steud. (Euphorbiaceae): Traditional uses, clinical applications, phytochemistry, pharmacology and toxicology
    Ya-Nan Li et al, 2021, Journal of Ethnopharmacology CrossRef
20. Plasma metabonomics study on toxicity biomarker in rats treated with Euphorbia fischeriana based on LC–MS
    Yingfeng Wang et al, 2016, Biomedical Chromatography CrossRef
21. Ethnomedicinal Uses, Phytochemistry and Pharmacological Properties of Suregada Genus: A Review
    Mandisa Mangisa et al, 2023, Pharmaceuticals CrossRef
22. Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca2+-mitochondria dependent pathway
    Jing Zhang et al, 2017, Oncotarget CrossRef
23. Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non‐small cell lung cancer cells
    Xiang Gao et al, 2018, Journal of Cellular Biochemistry CrossRef
24. A Nano-Traditional Chinese Medicine Against Lymphoma That Regulates the Level of Reactive Oxygen Species
    Qiangqiang Zhao et al, 2020, Frontiers in Chemistry CrossRef